Cementos Bio Bio S.A. (SNSE:CEMENTOS)

Cementos Bio Bio Income Statement

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	354,714	359,565	349,104	334,004	289,468	242,586
Revenue Growth (YoY)	-1.17%	3.00%	4.52%	15.38%	19.33%	-9.69%
Cost of Revenue	221,258	222,102	219,413	228,479	186,287	146,484
Gross Profit	133,456	137,462	129,692	105,525	103,181	96,102
Selling, General & Admin	98,128	97,800	94,685	94,110	86,095	73,039
Other Operating Expenses	394.42	445.7	120.09	-	-	-
Operating Expenses	98,522	98,245	94,805	94,110	86,095	73,039
Operating Income	34,934	39,217	34,887	11,415	17,086	23,062
Interest Expense	-10,296	-10,708	-14,353	-11,141	-3,561	-4,038
Interest & Investment Income	1,451	1,490	1,210	1,063	598.99	285.22
Currency Exchange Gain (Loss)	1,877	3,877	434.34	-1,311	1,425	-1,248
Other Non Operating Income (Expenses)	1,239	1,260	3,574	1,954	2,114	385.14
EBT Excluding Unusual Items	29,204	35,136	25,752	1,980	17,662	18,447
Gain (Loss) on Sale of Assets	3,658	5,265	556.51	3,427	8,655	1,178
Asset Writedown	-506.59	-508.61	-584.07	-2,550	-988.27	-3,478
Other Unusual Items	-	-	-	-	685.41	43.04
Pretax Income	33,433	40,970	26,622	5,635	33,911	16,263
Income Tax Expense	6,109	8,571	3,812	-4,926	6,885	2,351
Earnings From Continuing Operations	27,324	32,399	22,809	10,561	27,026	13,912
Minority Interest in Earnings	35.22	28.34	-12.25	-1.13	-146.9	-149.47
Net Income	27,359	32,427	22,797	10,560	26,879	13,763
Net Income to Common	27,359	32,427	22,797	10,560	26,879	13,763
Net Income Growth	-5.78%	42.24%	115.88%	-60.71%	95.30%	5.03%
Shares Outstanding (Basic)	264	264	264	264	264	264
Shares Outstanding (Diluted)	264	264	264	264	264	264
EPS (Basic)	103.55	122.73	86.28	39.97	101.73	52.09
EPS (Diluted)	103.55	122.73	86.28	39.97	101.73	52.09
EPS Growth	-5.78%	42.24%	115.88%	-60.71%	95.30%	5.03%
Free Cash Flow	52,547	54,336	24,086	9,374	3,860	24,226
Free Cash Flow Per Share	198.88	205.65	91.16	35.48	14.61	91.69
Dividend Per Share	-	-	36.000	12.000	48.000	42.000
Dividend Growth	-	-	200.00%	-75.00%	14.29%	162.50%
Gross Margin	37.62%	38.23%	37.15%	31.59%	35.64%	39.62%
Operating Margin	9.85%	10.91%	9.99%	3.42%	5.90%	9.51%
Profit Margin	7.71%	9.02%	6.53%	3.16%	9.29%	5.67%
Free Cash Flow Margin	14.81%	15.11%	6.90%	2.81%	1.33%	9.99%
EBITDA	46,225	53,550	48,082	24,159	30,270	34,832
EBITDA Margin	13.03%	14.89%	13.77%	7.23%	10.46%	14.36%
D&A For EBITDA	11,291	14,332	13,195	12,744	13,184	11,770
EBIT	34,934	39,217	34,887	11,415	17,086	23,062
EBIT Margin	9.85%	10.91%	9.99%	3.42%	5.90%	9.51%
Effective Tax Rate	18.27%	20.92%	14.32%	-	20.30%	14.45%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.